LCTX Financials
Lineage Cell Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$213.56M
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$9.50M
Gross Profit
-
Operating Income
-
Net Income
$-18.58M
EPS (Diluted)
$-0.09
Balance Sheet Highlights
Total Assets
$113.22M
Total Liabilities
$36.21M
Shareholders Equity
-
Cash & Equivalents
$45.79M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-23.09M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LCTX revenue?
LCTX's most recent quarterly revenue was $9.50M. Annual revenue can be calculated by summing the four most recent quarters.
Is LCTX profitable?
LCTX reported a loss of $18.58M in the most recent quarter.
What is LCTX market cap?
LCTX has a market capitalization of $213.56M, making it a small-cap stock.
Does LCTX have debt?
View LCTX's balance sheet for debt information.
What is LCTX cash flow?
Cash flow data is available in the full financial statements.